| Kristen Naomi Winterringer, PMHNP (APRN) | |
|
1028 Walnut St, Yankton, SD 57078-2910 | |
| (605) 665-4606 | |
| Not Available |
| Full Name | Kristen Naomi Winterringer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 1028 Walnut St, Yankton, South Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568086064 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | CP001762 (South Dakota) | Primary |
| Entity Name | Lewis & Clark Behavioral Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215918339 PECOS PAC ID: 9436145273 Enrollment ID: O20040426000387 |
News Archive
AstraZeneca today asked the U.S. Food and Drug Administration (FDA) to adopt guidance that will enable AstraZeneca and others to fully engage in real-time, social media conversations that responsibly provide accurate, balanced information on medicines from a known, identifiable and reliable source.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
Poniard Pharmaceuticals today announced the sale of 3,489,728 of its common shares to Azimuth Opportunity Ltd. for net proceeds of approximately $6.5 million, or approximately $1.87 per share, under its existing committed equity financing facility with Azimuth.
Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure.
› Verified 9 days ago
| Entity Name | Midwest Wellness Institute Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851729552 PECOS PAC ID: 3072743079 Enrollment ID: O20140312001164 |
News Archive
AstraZeneca today asked the U.S. Food and Drug Administration (FDA) to adopt guidance that will enable AstraZeneca and others to fully engage in real-time, social media conversations that responsibly provide accurate, balanced information on medicines from a known, identifiable and reliable source.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
Poniard Pharmaceuticals today announced the sale of 3,489,728 of its common shares to Azimuth Opportunity Ltd. for net proceeds of approximately $6.5 million, or approximately $1.87 per share, under its existing committed equity financing facility with Azimuth.
Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Naomi Winterringer, PMHNP (APRN) 1028 Walnut St, Yankton, SD 57078-2910 Ph: (605) 665-4606 | Kristen Naomi Winterringer, PMHNP (APRN) 1028 Walnut St, Yankton, SD 57078-2910 Ph: (605) 665-4606 |
News Archive
AstraZeneca today asked the U.S. Food and Drug Administration (FDA) to adopt guidance that will enable AstraZeneca and others to fully engage in real-time, social media conversations that responsibly provide accurate, balanced information on medicines from a known, identifiable and reliable source.
Mylan Inc. today announced that it has entered into settlement agreements with Takeda Pharmaceutical Co. related to two treatments for type 2 diabetes: Actoplus Met®, 15 mg/500 mg and 15 mg/850 mg, known generically as Pioglitazone Hydrochloride (HCl) and Metformin HCl Tablets, and Actos®, 15 mg, 30 mg and 45 mg, known generically as Pioglitazone HCl Tablets.
Poniard Pharmaceuticals today announced the sale of 3,489,728 of its common shares to Azimuth Opportunity Ltd. for net proceeds of approximately $6.5 million, or approximately $1.87 per share, under its existing committed equity financing facility with Azimuth.
Cancer stem cells are particularly difficult to eradicate and are at the heart of why it is so hard to more effectively treat cancer patients, as the post-treatment survival of cancer stem cells drives tumour recurrence, the systemic spread of cancer and, ultimately, treatment failure.
› Verified 9 days ago
Elizabeth Ann Wortmann, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 | |
Holly Haberman, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 409 Summit St, Suite # 3400, Yankton, SD 57078 Phone: 605-260-0310 | |
Dr. Stacy Kristin Kotalik, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 409 Summit St Ste 2500, Yankton, SD 57078 Phone: 605-655-1710 Fax: 605-655-1711 | |
Whitney J Delforge, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Elizabeth Kemper Eggers, MSN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3515 Broadway Ave., Yankton, SD 57078 Phone: 605-668-3100 Fax: 605-668-3460 | |
Chelsie Promes, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1104 W 8th St, Yankton, SD 57078 Phone: 605-665-7841 Fax: 605-665-0546 | |
Karla Walsh, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3515 Broadway Ave, Yankton, SD 57078 Phone: 605-668-3100 Fax: 605-668-3460 |